Clinical trials
Active, not recruiting Uterine Cervical Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Cancer Research, United Kingdom | 2 |
| Alterome Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| Cancer Research UK | 1 |
| Grey Wolf Therapeutics | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Taiho Oncology, Inc. | 1 |
| The Clatterbridge Cancer Centre NHS Foundation Trust | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 12 |
| Endometrial Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Ovarian Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Colorectal Neoplasms | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.